CCC

COEGIN PHARMA

No trades
See on Supercharts
Market capitalization
‪48.20 M‬SEK
−2.84SEK
‪−35.24 M‬SEK
Beta (1Y)
1.22

About COEGIN PHARMA

CEO
Tore Duvold
Headquarters
Lund
Employees (FY)
3
Founded
2016
ISIN
SE0020357754
FIGI
BBG00JDRC616
Coegin Pharma AB engages in biotechnology research and experimental development. Its nanotechnology is designed to manage inflammatory diseases and cancer. The firm also offers consultancy and management services. The company was founded in 2005 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of COEGIN is 3.02 SEK — it has increased by 4.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange COEGIN PHARMA stocks are traded under the ticker COEGIN.
COEGIN stock is 5.17% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is COEGIN PHARMA there?
Yes, you can track COEGIN PHARMA financials in yearly and quarterly reports right on TradingView.
COEGIN stock has risen by 11.44% compared to the previous week, the month change is a 13.96% rise, over the last year COEGIN PHARMA has showed a 77.96% decrease.
COEGIN net income for the last quarter is ‪−7.14 M‬ SEK, while the quarter before that showed ‪−6.52 M‬ SEK of net income which accounts for −9.40% change. Track more COEGIN PHARMA financial stats to get the full picture.
No, COEGIN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, COEGIN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COEGIN PHARMA stock right from TradingView charts — choose your broker and connect to your account.
COEGIN reached its all-time high on Mar 22, 2018 with the price of 263.39 SEK, and its all-time low was 1.16 SEK and was reached on Apr 15, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 3.00 employees. See our rating of the largest employees — is COEGIN PHARMA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COEGIN PHARMA technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COEGIN PHARMA stock shows the sell signal. See more of COEGIN PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.